Gossamer Bio's total assets for Q1 2026 were $128.90M, a decrease of -25.17% from the previous quarter. GOSS total liabilities were $290.38M for the fiscal quarter, a -1.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.